Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,729.97
+0.09%
DAX
26,249.24
-0.34%
CAC 40
8,566.42
-0.15%
STOXX 50
6,507.77
-0.35%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Friday 05 March 2021 6:03 pm  |  Updated:  Friday 05 March 2021 8:12 pm

Matt Hancock: Vaccines are breaking the ‘unbreakable link’ between Covid cases and deaths

By: Poppy Wood

Add as a preferred source on Google
Matt Hancock wanted to decide “who should live and who should die” if hospitals were overwhelmed during the pandemic, the UK’s official Covid-19 inquiry has been told.
Matt Hancock wanted to decide “who should live and who should die” if hospitals were overwhelmed during the pandemic, the UK’s official Covid-19 inquiry has been told.

The “unbreakable link” from Covid cases to hospitalisations and deaths is now being broken as Britain begins to emerge from the grips of the pandemic, the health secretary has said.

Latest official data showed infections have fallen 34 per cent over the past week, as the UK makes rapid progress with the vaccine rollout.

Speaking at a Downing Street press conference, Matt Hancock said hospital admissions plunged dramatically over the past seven days, and are falling around 30 per cent every week.

The most recent seven-day drop marked the fastest decline in coronavirus-related hospitalisations at any point in the pandemic.

Meanwhile, deaths within 28 days of a positive coronavirus test fell 41 per cent in the past week, which the heath secretary said “really [showed] the effects of the vaccine”.

“The link from cases to hospitalisations and to deaths, that had been unbreakable before the vaccine — that link is now breaking. The vaccine is protecting the NHS and saving lives right across the country,” he added.

It comes as more than 21.3m people across the country have now received their first dose of a Covid vaccine — equivalent to around two two-fifths of the entire adult population.

The government has set a fresh target to offer an injection to all over-50s by 15 April, and all adults in the UK by 31 July.

Read more

Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

However, Hancock urged cautious optimism over the decline in cases, adding that regular testing will be key to lifting lockdown measures.

“One of the most dangerous things about this virus is that around one third of those who get it will have no symptoms and yet they can still pass it on to others,” he said this evening.

“Rapid regular testing is a critical part of our response and we can do more because of the huge capacity built up by Test and Trace,” Hancock added.

The contact tracing scheme, which has so far received £22bn from the taxpayer, is set to receive an extra £15bn over the net financial year — bringing its total funding to £37bn.

Hancock said he was “delighted” at Test and Trace’s success in locating a sixth person infected with a new Brazil variant of coronavirus, after a week-long hunt.

The missing individual, who had failed to fill in their contact details on their test registration form, was located in the London borough of Croydon.

Further precautionary testing will take place in Croydon in light of the discovery, alongside sample sequencing to ensure that there are no further cases in the community.

Read more

Tate & Lyle faces shareholder revolt over executive pay

Tate & Lyle logo, a global food ingredients supplier, on a corporate building.

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business
  • Politics

Related Topics

  • Coronavirus
  • Re-lockdown
  • Vaccine

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Aldi boss wades into supermarket ‘price-gouging’ row

  • Monzo chair makes early exit after boardroom rift

  • New Premier League rules could see £11bn invested into new stadiums

More from Morning Wire

  • Cycle Pharmaceuticals Selects Forma Life Sciences to Establish U.S. Commercial Supply for FDA-Approved CAVHANZA™ (nilotinib) Orally Disintegrating Tablets

    Business Wire
  • Tate & Lyle faces shareholder revolt over executive pay

    Retail
    Tate & Lyle logo, a global food ingredients supplier, on a corporate building.
  • UK debt ‘hits £3 trillion’ milestone

    Economics
    Houses of Parliament in Westminster showcasing historic architecture under a clear sky, central to UK government and politics
  • Deloitte warns of ‘challenges ahead’ for European football despite €40bn milestone

    Sport Business
    Getty Images logo on office building exterior under clear blue sky, representing global media and stock photography company
  • Andy Burnham pressured to safeguard jury trials after legal backlash

    Legal
    Andy Burnham speaking at a press conference, addressing current events and regional developments, wearing a suit and tie.
  • Crown Prosecution Service caught using AI hallucination evidence

    AI
    Chicago Public Schools building exterior with students entering, reflecting urban education theme in a news article context.
  • World Cup: England must do it for the Falklands

    Opinion
    England football team players celebrate on the field with fans in the background during an international match.
  • Tiktok ‘confident’ ahead of Ofcom child safety probe

    Tech
    Tiktok appeals to overturn US ban in a broader battle for tech regulation
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook